Gilead in the news

Gilead Sciences, a biopharmaceutical company, has been in the news for various reasons. Here are some recent news articles and updates:

  1. Remdesivir: COVID-19 treatment: Gilead's antiviral drug remdesivir has been in the spotlight as a potential treatment for COVID-19. The company has been working with governments and health organizations to make the drug available to patients worldwide.
  2. Veklury: FDA approval: In October 2020, the US Food and Drug Administration (FDA) approved remdesivir under the brand name Veklury for the treatment of COVID-19 in hospitalized patients.
  3. Pricing controversy: Gilead has faced criticism for the high price of Veklury, with some arguing that it is too expensive for many patients and healthcare systems. The company has defended its pricing, citing the complexity and cost of developing the drug.
  4. Licensing agreements: Gilead has entered into licensing agreements with other companies to manufacture and distribute Veklury, including a deal with generic drugmaker Cipla to supply the drug to low- and middle-income countries.
  5. Pipeline updates: Gilead has been working on several other pipeline projects, including treatments for HIV, hepatitis B, and liver cancer. The company has also been investing in gene therapy and cell therapy research.
  6. Acquisitions and partnerships: Gilead has made several acquisitions and partnerships in recent years, including the purchase of Immunomedics, a biotech company developing cancer treatments, and a partnership with Novartis to develop gene therapies.
  7. Executive changes: In 2020, Gilead's CEO, Daniel O'Day, stepped down and was replaced by John Milligan, who had previously served as the company's chief operating officer.
  8. Financial performance: Gilead has reported strong financial performance in recent years, driven by the success of its HIV and hepatitis C treatments, as well as the growth of its pipeline products.
  9. Sustainability initiatives: Gilead has been working to reduce its environmental impact and improve its sustainability practices, including reducing energy consumption and waste, and increasing the use of renewable energy.
  10. Philanthropic efforts: Gilead has been involved in various philanthropic efforts, including the Gilead Foundation, which focuses on supporting organizations working to address health disparities and improve access to healthcare.

These are just a few examples of the news and updates related to Gilead Sciences. If you're looking for more information, I can try to help you find specific articles or updates on a particular topic.